THE SEVEN COUNTRIES STUDY: THE LESSONS FOR CARDIOVASCULAR SPECIALISTS

Size: px
Start display at page:

Download "THE SEVEN COUNTRIES STUDY: THE LESSONS FOR CARDIOVASCULAR SPECIALISTS"

Transcription

1 194 THE SEVEN COUNTRIES STUDY: THE LESSONS FOR CARDIOVASCULAR SPECIALISTS ALESSANDRO MENOTTI, MD, PhD, for the SEVEN COUNTRIES STUDY RESEARCH GROUP The Seven Countries Study (SCS) is a classical epidemiological observational study that began in the 1950s and was carried out for 25 years. The study had 16 population samples of men, aged 40 to 59 y at entry, who live in seven different countries in three continents (United States, Japan, Finland, The Netherlands, Italy, former Yugoslavia, and Greece). At entry field examination, several individual characteristics of biophysical, biochemical, behavioral, clinical, and nutritional variables were measured. Similar examinations were repeated after 5 and 10 years. Incidence of cardiovascular diseases was measured for the first 10 years of follow-up and vital status and causes of death for 25 years. The SCS was the first study to demonstrate the existence of true differences in prevalence, incidence, and mortality from coronary heart disease (CHD) among different and contrasting populations, with higher rates in North America and northern Europe and lower rates in southern Europe and Japan. A large proportion of these differences could be attributed to population differences in nutrient intake and risk factors. High, positive, and significant correlations and regression coefficients were found in CHD at mean levels, mainly in saturated fatty-acid consumption and serum cholesterol and partly in blood pressure. Moreover, the relationship of risk factors to individual risk ofchd was found within each country. These findings became the empirical and theoretical bases for the population strategy of primary prevention of CHD, having shown the mass origin of mass morbid phenomenon. AFTER THE Second World War, in the 1950s, several investigators discussed their interest of studying a new epidemic which began to affect industrialized countries. The decline in morbidity and mortality from infectious diseases and malnutrition was largely substituted by increasing trends in morbidity and mortality from cardiovascular diseases, particularly coronary heart disease (CHD). However, there were substantial uncertainties about the real dimension of the phenomenon, the existence of real differences in morbidity and mortality from CHD among populations, and the possible causes of the disease and its widespread diffusion. During this time, the era of cardiovascular epidemiology began and some From the Division of Epidemiology, University of Minnesota, Minneapolis, Minnesota, USA, and Cardioricerca, Rome, Italy. Address reprint requests and correspondence to Dr. Menotti: Cardioricerca, Via Adda 87, Rome 00198, Italy. historically classic studies were carried out. Among them, the Seven Countries Study of Cardiovascular Diseases was the first study to pose questions and to seek for answers at the intemationallevel. A group of scientists with different backgrounds, led by Professor Ancel Keys, from the University of Minnesota, promoted this study after years of exploratory and pilot studies and after developing a standardized methodology that had been strictly tested. The Seven Countries Study (SCS) tried to answer the following questions: (1) whether different and contrasting populations suffered real differences in cardiovascular diseases, in general, and CHD, in particular; (2) whether these differences, if any, could be partly explained by lifestyles, eating habits, and other general characteristics of the populations themselves; and (3) whether, within each population, individual characteristics (later named risk factors) were able to predict the occurrence of CHD morbid and fatal events.

2 SEVEN COUNTRIES STUDY Materials and Methods The entry examination of the SCS was held between 1958 and 1964 on 12,763 men, aged 40 to 59 y, in 16 cohorts in seven counties.i.2 Eleven cohorts comprised more than 95% of all men in that age range in geographically-defined rural areas in Finland (2 cohorts), Italy (2 cohorts), former Yugoslavia ( 3 cohorts), Greece (2 cohorts), and Japan (2 cohorts). A statistically-defmed four-ninths sample of all men, aged 40 to 59 y, was enrolled in Zutphen, a small commercial town in The Netherlands. A cohort was provided by a large agroindustrial cooperative in Zrenjanin, Serbia (Yugoslavia) and another was made up of faculty of the University of Belgrade (Yugoslavia). Finally, two cohorts of railroad employees in specific occupations were enrolled, one trom the midwest and northwest of the United States and the second from the Rome Division of the Italian State Railroad. Overall, participation rate was more than 90%, with several cohorts reaching close to 100%.J A number of measurements were taken at entry and subsequent examinations, including information on lifestyle obtained by questionnaire, the measurement of biophysical and biochemical variables, a clinical questionnaire and physical examination, recording of blood pressure, resting and post-exercise electrocardiograms, and data on dietary habits; the information was collected by different methods. 1-5 Similar examinations were repeated after 5 and 10 years, and in some cohorts also after 15,20, and 25 years. Incidence of major cardiovascular diseases was estim'ltf"n for the first 1 0 years in all cohorts. Data on vital status, mortality, and causes of death were collected in all cohorts for 25 years with minimal losses to follow-up (56 subjects, more than 12,000). Details on methods, procedures, and criteria can be found elsewhere.i-j In general, methods and procedures for most measurements were highly standardized, under strict quality control and, when possible, centralized (such as cholesterol measurement, chemical analysis of food composites, ECG readings and coding, final allocation of clinical diagnoses, and causes of death). Analyses for the report followed two different approaches: (1) the ecological approach, when the statistical units were made of single cohorts or pools of national cohorts (inter-cohort comparisons); in this context, for some purposes, former Yugoslavia was split into two components, i.e., Croatia and Serbia, due to their background differences as different nations; and (2) the individual approach, when the statistical units were made of individuals within single cohorts or nations, or within larger pools (inter-individual comparisons). Both univariate analyses and different multivariate models were considered. Differences Among Cohorts in Risk Factor Levels, Incidence, and Mortality from CUD Identification of cohorts, number of men examined, and participation rates are given in Table 1. At entry examination, large differences were found in mean levels of some cardiovascular risk factors and personal characteristics among cohorts. In particular, serum cholesterol was the highest in Finland, United States, and The Netherlands (> 6 mmolll), lower in southern Europe ( ::; 5.4 mmol/l), and with lowest levels in Serbia (former Yugoslavia) and Japan.I.2 Blood pressure was also higher in northern European cohorts than in other groups but differences were smaller. 1,2 The highest prevalence of smokers was found in The Netherlands and in Japan.I.2 The most contrasting eating habit was the intake of saturated fatty acids, ranging between 20% and above (as proportion of total energy intake) in Finland, The Netherlands and United States; in southern Europe and Japan2.4.5the percentages were 10% and 3%, respectively. CHD incidence and mortality, for variable periods of follow-up. This approach usually considered the use of regression equations and correlations, with mean population levels of risk factors as independent variables and CHD incidence or mortality rates as dependent variables. During follow-up, CHD incidence (for the first 10 years) and CHD mortality (for several variable periods offollow-up, up to 25 years) strongly and significantly correlated to population levels of serum cholesterol, systolic and diastolic blood pressure among risk factors, and saturated fat consumption, the ratio of polyunsaturated to saturated fatty-acid (PIS ratio) consumption (inverse), the ratio of monounsaturated to saturated fatty-acids (MIS ratio) (inverse), and carbohydrates among major nutrients. Poor relationships were found with body mass index, smoking habits, and skinfold thickness. Highly significant correlations were also found between population intake of saturated fatty acids and population mean levels of serum cholesterol This means that, at least ITom the observational point of view, high levels of serum cholesterol and blood.

3 196 MENOTII The early results ofthe study, related to the first 5 years of follow-up, showed for the first time the existence of large and true differences in prevalence, incidence, and mortality from CHD among different nations and different cohorts in different countries, studied by the same standardized protocoj.2 Those early data showed the highest levels ofchd incidence and mortality in northern European (particularly in Finland) and north American samples, lower or definitely low levels in southern European and Mediterranean cohorts, and very low levels in Japan (Table 2). Overall, the difference in 5-year incidence was about lo-fold comparing Finland with Japan and about IS-fold comparing the cohort with the highest level (East Finland) with that having the lowest level (Crete). These differences roughly reflected those suggested by the official mortality data that have been collected, collated, and distributed by the World Health Organization. Findings by the SCS, however, were based on a standardized and comparable methodology. Similar experience was found for CHD incidence after Table 2. Five-year incidence per 10,000 ofchd events in CHDfree men at entry examination in seven countries. * Country CHD Myocardial Angina Other All death infarction pectoris CHD CHD Finland United States Netherlands Italy Yugoslavia Greece Japan *From the Seven Countries of Cardiovascular Diseases. CHD = coronary heart disease. Table 3. Rank position of cumulative quinquennial death rates from typical CHD (sudden death andfatal myocardial infarction) during 25 years offollow-up. * Country 5 Years 10 Years 15 Years 20 Years 25 Years Finland United States Netherlands Italy Croatia Serbia Greece Japan *From the Seven Countries Study of Cardiovascular Diseases. CHD = coronary heart disease. 10 years of follow-up.3 Comparisons of cumulative death rates from CHD at quinquennial intervals (from year 5 up to year 25) confirmed the wide range of CHD mortality among cohorts and nations.6.7 However, changes in the rank order of death rates were recorded among nations after a 10-year followup, with the Serbian cohorts overtaking all the other southern European groups, from low levels to cumulative rates that are similar to those of northern Europe (Table 3). Explanation of Inter-cohort Differences in the Burden of CHD A number of "ecological" analyses were conducted to relate entry population levels of risk factors and other personal characteristics to CHD incidence and mortality, for variable periods of follow-up. This approach usually considered the use of regression equations and correlations, with mean population levels of risk factors as independent variables and CHD incidence or mortality rates as dependent variables. During follow-up, CHD incidence (for the first 10 years) and CHD mortality (for several variable periods offollow-up, up to 25 years) strongly and significantly correlated to population levels of serum cholesterol, systolic and diastolic blood pressure among risk factors, and saturated fat consumption, the ratio of polyunsaturated to saturated fatty-acid (PIS ratio) consumption (inverse), the ratio of monounsaturated to saturated fatty-acids (MIS ratio) (inverse), and carbohydrates among major nutrients. Poor relationships were found with body mass index, smoking habits, and skinfold thickness. Highly significant correlations were also found between population intake of saturated fatty acids and population mean levels of serum cholesterol This means that, at least ITom the observational point of view, high levels of serum cholesterol and blood pressure and a rich diet (rich in fat and saturated fatty acids and poor in poly- and monounsaturated fatty acids) are associated with higher incidence and mortality from CHD and vice versa. Examples of these correlations are given in Tables 4 and 5. After 25 years of follow-up, the relationship of population mean levels of serum cholesterol to CHD mortality, although still positive and significant, was definitely weaker than for shorter follow-up periods6 due to changes in the rank order of CHD death rates, particularly for southern European cohorts such as the ones in Serbia. Journal of the Saudi Heart Association, \obi. 9, No.3, 1997

4 SEVEN COUNTRIES STUDY 197 Table 4. Correlation coefficients between population mean levels 0/ some risk/actors and CHD events. * Population CHD Follow-up Correlation Lower CI risk factor end-point duration (y) coefficient Cholesterol Incidence Cholesterol Death Cholesterol Death Systolic BP Death Systolic BP Death Cigarettes Death Cigarettes Death Body mass index Death Body mass index Death Physical activity Death Physical activity Death Multiple regressiont Death Multiple regressiont Death *From the Seven Countries Study of Cardiovascular Diseases twith cholesterol, systolic blood pressure, cigarettes, body mass index, and physical activity as predictors. CHD = coronary heart disease; CI = confidence interval; BP = blood pressure. Upper CI Table 5. Correlation coefficients between population mean levels 0/ some nutrient intake and CHD event rates in 16 cohorts. * Population CHD Follow-up Correlation Lower CI Upper CI nutrient end-point duration (y) coefficient Total fat Incidence Total fat Death Saturated fats Incidence Saturated fats Death Monounsaturated fats Incidence PIS ratio Death MIS ratio Death Omega-3 fatty acids Death Proteins Incidence 5 O Carbohydrates Death *From the Seven Countries of Cardiovascular Diseases. CHD = coronary heart disease; CI = confidence interval. Prediction of CHD Events by Multivariate Approach Incidence and mortality trom CHD for different follow-up periods, for single cohorts, pools of national cohorts, and pools of nations were used as end-points in multivariate estimates of predictivity as a function of individual characteristics known as cardiovascular risk factors. Pooling of cohorts was needed when, during short follow-up periods, incident or fatal events were too few in single cohorts. The most commonly used models were the multiple logistic function and the proportional hazards model. Examples are given in Table 6. Basically, age, serum cholesterol, systolic (and diastolic) blood pressure, smoking habits and, to a lesser extent, body mass index and sedentation were directly related to the occurrence of new CHD events or to CHD deaths, with "weights" determined by the estimated coefficients of the multivariate models '2-'4 The back application of coefficients and constant of the equation to single individuals of the same population which produced the model allowed to estimate and to rank the individual probabilities of a CHD event in a given period of time. These probabilities increased in subgroups with low estimated risk to groups with high estimated risk, with large correlation coefficients between estimated and observed CHD cases in these subgroups. The risk ratio between extreme classes was in the range of 5 to 10 and above, depending upon the model.

5 198 MENOITI Table 6. Solutions of the multiple logistic function with six riskfactors predicting coronary deaths in 10 years in three regions. * Region Const. Age SBP CHOL CIG PULSE PHY ACT USA coeff SE T-value O.ll * From the Seven Countries Study of Cardiovascular Diseases. USA = United States of America; NEU = northern Europe; SEU = southern Europe; SBP = systolic blood pressure; CHOL = serum cholesterol; CIG = cigarettes consumption; PULSE = pulse rate; PHY ACT = physical activity. Table 7. Prediction ofchd deaths in one regionfrom the logistic coefficients of another region. Model with 5 riskfactors predicting events in J 5 years. * Solutions Predicting CHD Ratio expected/ deaths in observed SEU NEU 0.53 SEU USA 0.76 SEU Japan 2.17 NEU SEU 1.89 NEU USA 0.99 NEU Japan 4.54 USA SEU 1.92 USA NEU 1.04 USA Japan 4.54 Japan SEU 0.20 Japan NEU 0.06 Japan USA 0.09 *From the Seven Countries Study of Cardiovascular Diseases. CHD = coronary heart disease; SEU = southern Europe; NEU = northern Europe. Although bound only to these observational data, these findings suggested the likelihood of a multifactorial predictivity (if not causality) ofchdy, However, when the same back application was made, applying the coefficients of one population to the risk factor levels of another, the ranking of the risk (relative risk) was equally good3.7.9 but the estimate of absolute risk (Le., the actual number of cases) could be over- or underestimated as shown in Table 7. For example, the risk function of northern European cohorts overestimated incidence in southern Europe (and vice versa, the risk function of southern Europe underestimated incidence in northern Europe). On the other hand, risk functions of CHD from northern European cohorts predicted in an accurate way the incidence in North America and vice versa, suggesting that background ethnic factors or other factors, not measured in this study, were responsible for the proportion in differential incidence and mortality from Table 8. Relative risk ofchd mortality riskfor a difference of about J mmol/l (40 mg/dl) in serum cholesterol and 20 mm Hg in systolic blood pressure. estimated in 8 nations by proportional hazards multivariate models. * Nation Cholesterol Systolic BP RR Lower CI Upper CI RR Upper CI Lower CI USA Finland Netherlands Italy Croatia Serbia Greece Japan *From the Seven Countries Study on Cardiovascular Diseases CHD = coronary heart disease; BP = blood pressure; RR = relative risk; CI = confidence interval.

6 SEVEN COUNTRIES STUDY 199 CHD that were not explained by the available factors. In extensive analyses made on the 25-year mortality data,14 it was shown that for some major risk factors, the relative risk of CHD death for defmed differences in risk factor levels are largely similar in different populations and cultures (Table 8). This means that the biological and statistical relation of risk factors, such as serum cholesterol and blood pressure, to the disease is basically the same in different cultures and that differences in incidence and mortality are mainly due to different mean levels in risk factors, and, of course, to other unknown or nonmeasured factors. 14 Secular Trends in Population Risk Factor Levels and CUD Mortality During follow-up and repeated examinations, population mean levels of risk factors changed. A part of the change was related to the contemporary aging of population samples whose follow-up began at the same age range and with similar distributions. The change was very different among populations, suggesting that different secular trends are related to local circumstances. Trends in smoking habits were linked to a natural and expected decline with aging. Trends in blood pressure and serum cholesterol levels were different among different cohorts.3.6a summary of to-year changes is given in Table 9. In general, population serum cholesterol levels were relatively stable or declined in the United States, Finland, The Netherlands, and Japan, while there were increases in southern Europe, mainly in Serbian cohorts. At the same time, CHD death rates showed different trends among populations, with extraordinary relative increases in southern Europe and mainly in Serbian cohorts.6 For explanation of these differences, ecological analyses that included entry levels of population serum cholesterol, their changes in the first 10 years of follow-up, and the possible association with CHD rates in the next 15 years6 were studied. A multiple linear regression equation describing this approach (Table 10) suggests that CHD death rates between years 10 and 25 of follow-up are both predicted by entry levels of serum cholesterol (year 0) and by their I O-year changes, confmning the possibility that mass population changes (mainly increases) of serum cholesterol are followed by higher levels ofchd death rates. This corresponds to a type of observational natural experiment, bound to an inverse direction, compared with primary prevention trials. Table 9. Mean changes (percent) in serum cholesterol and systolic blood pressure levels during the first 10 years of follow-up in 16 cohorts. * Cohort US Railroad, USA CHOL SBP (5 years) (5 years) East Finland, Finland West Finland, Finland Zutphen, Netherlands Crevalcore, Italy + II Montegiorgio, Italy Rome Railroad, Italy Dalmatia, Croatia Siavonia, Croatia Velika Krsna, Serbia Zrenjanin, Serbia Belgrade, Serbia Crete, Greece Corfu, Greece Tanushimaru, Japan Ushibuka, Japan *From the Seven Countries Study of Cardiovascular Diseases. CHOL = serum cholesterol; SBP = systolic blood pressure. Table 10. Multiple linear regression ofchd death rates on 5 risk factors at entry and difference of cholesterol at year 10 minus cholesterol at year a (D-cholesterol-l 0) in the studied cohorts. The first 10 years offollow-up are excluded. * Risk factors t-values for follow-up of 10-15years years Cholesterol D-cholesterol-IO Body mass index Cigarettes Physical activity Systolic BP R R squared *From the Seven Countries of Cardiovascular Diseases. CHD = coronary heart disease; BP = blood pressure. Individual Changes in Risk Factors and Prediction of Cardiovascular Diseases During follow-up, changes in risk factor levels affected single individuals within cohorts, nations, and countries in different ways. The role of risk factor changes could therefore be also studied at individual levels and within cohorts, beyond the ecological change levels as described above. However, blood pressure was the only risk factor studied for individual changes,

7 200 MENOTII while only preliminary analyses were attempted for serum cholesterol and other factors. Changes in blood pressure during the first 10 years of follow-up (based on three measurements, corresponding to years 0,5, and 10) were estimated by different indicators such as the difference between levels at year 10 and year 0 or the risk-factor time integral, called delta. IS These changes have been used in a dycotomic way (subjects with relatively increasing V s are those with relatively decreasing levels identified by the median change) or as continuous variables"s The first approach is exemplified by Table II, where the relative risk of cardiovascular disease death between years I 0 and 20 of follow-up is reported (relative increase Vs and relative increase of blood pressure) in quartile classes of entry (year 0) blood pressure. In almost all cells, the relative risk is greater than one saying that, baseline blood pressure being similar, those exhibiting an increase of blood pressure are at higher risk for cardiovascular death than those exhibiting a decrease. This was true in different quartiles and in different cultures, as suggested by Table II where six national groups are compared. Similar conclusions were reached with a multivariate approach where blood pressure and its changes were fed as continuous variables. These findings somehow anticipated or confirmed results of drug trials of hypertension, but were bound to "spontaneous" change in blood pressure in individuals belonging to whole population groups and not to drug intervention in hypertensives only. In fact, changes in blood pressure were recorded in the I960s when treatment of high blood pressure was extremely rare and ineffective in these populations. These findings, too, represent a type of natural experiment observed among these different populations, although the precise causes of blood pressure changes are unknown. Conclusions Many other additional findings were found from the analyses of this study, at both intemationap6-39 and national levels. Although the study ended after 25 years of follow-up, it is still continuing with another name and organization in five areas of three countries (FINE Study: Finland, Italy, Netherlands Elderly), emphasizing health problems in the elderly and with a follow-up of35 years. The SCS is a classic study which has achieved some milestones in the knowledge of CHD epidemiology, causality, and prevention. The main lessons for clinicians and public health professionals can be summarized as follows: (1) different and contrasting populations may suffer largely different amounts of CHD; (2) large proportions of these differences, and perhaps causality, can be explained by different major lifestyles and characteristics of the populations, mainly in eating habits and population levels of serum cholesterol and partly in blood pressure; (3) within populations, the prediction of CHD events can be satisfactorily achieved by combining several risk factors in multivariate models; (4) population secular changes in serum cholesterol are followed by directly related changes in CHD mortality rates; and (5) individual changes in blood pressure are followed by different outcomes in cardiovascular disease mortality, with higher risk for those whose blood pressures relatively increase in years. These fmdings suggest that mass diseases, such as CHD, are largely due to mass phenomena and lifestyles, which could represent large portions in the causality of this condition. These facts represent the basis for the so-called population strategy of primary prevention, which points to substantial mass changes in lifestyle and distribution of major risk factors. Table II. Relative risk of CVD death for increase Vs decrease of SSP (expressed by an indicator of change) in age specific quartile classes of entry ssp. Changes of SSP in 10 years are related to mortality from CVD during the next 10 years.. Finland Netherlands Italy Yugoslavia Greece Japan Quartile I Quartile Quartile Quartile Surnrnaryt Frorn the Seven Countries Study of Cardiovascular Diseases. tmantel-haenszel technique. CVD = cardiovascular disease; SSP = systolic blood pressure.

8 SEVEN COUNTRIES STUDY 201 References 1. Keys A, Blackburn HW, Van Buchem FSP, et al. Epidemiological studies related to coronary heart disease: characteristics of men aged in seven countries. Acta Med Scand 1967;469 SuppI180: Keys A, Blackburn H, Menotti A, et al. Coronary heart disease in seven countries. Circulation 1970;41 Suppl I: Keys A, editor. Seven Countries Study. A multivariate analysis of death and coronary heart disease. Cambridge Mass: Harvard Univ Press; Den Hartog C, Buzina R, Fidanza F, Keys A, Roine P, editors. Dietary studies and epidemiology of heart disease. The Hague: Stichting tot wetenschappelijke Voorlichting op Voedingsgebied; Kromhout 0, Keys A, Aravanis C, et al. Food consumption patterns in the 1960s in seven countries. Am J Clin Nutr 1989;49: Menotti A, Keys A, Kromhout 0, et ai. Inter-cohort differences in coronary heart disease mortality in the 25-year follow-up of the Seven Countries Study. Eur J EpidemioI1993;9: Keys A, Menotti A, Aravanis C, et al. The Seven Countries Study: 2289 deaths in 15 years. Prev Med 1984;13: Keys A, Aravanis C, Van Buchem F, et al. The diet and all causes death rate in the Seven Countries Study. Lancet 1981;2: Keys A, Menotti A, Karvonen MJ, et al. The diet and 15-year death rate in the Seven Countries Study. Am J Epidemiol 1986; 124: Menotti A, Keys A, Aravanis C, et al. Seven Countries Study. First 20-year mortality data in 12 cohorts of the Seven Countries. Ann Med 1989;21: II. Kromhout 0, Menotti A, Bloemberg B, et ai. Dietary saturated and trans-fatty acids and cholesterol and 25-year mortality from coronary heart disease: the Seven Countries Study. Prev Med 1995;24: Keys A, Aravanis C, Blackburn H, et al. Probability of middleaged men developing coronary heart disease in five years. Circulation 1972;45: Keys A, Aravanis C, Blackburn H, et al. Coronary heart disease: overweight and obesity as risk factors. Ann Intern Med 1972;77: Menotti A, Keys A, Blackburn H, et al. Comparison of multivariate predictive power of major risk factors for coronary heart disease in different countries: results from eight nations of the Seven Countries Study, 25-year followup. J Cardiovasc Risk 1996;3: Menotti A, Keys A, Blackburn H, et al. Blood pressure changes as predictors of future mortality in the Seven Countries Study. J Hum Hypertens 1991;5: Keys A, Aravanis C, Blackburn H, et al. Lung function as a risk factor for coronary heart disease. Am J Public Health 1972;62: Keys A, Fidanza F, Karvonen MJ, et al. Indices of relative weight and obesity. J Chron Dis 1972;25: Rautaharju PM, Punsar S, Blackburn H, et al. Waveform patterns in Frank lead rest and exercise electrocardiogram of healthy elderly men. Circulation 1973;48: Rose GA, Blackburn H, Keys A, et ai. Colon cancer and blood cholesterol. Lancet 1974;1: Menotti A. Obesity: a risk factor of coronary heart disease. Arch Mal Coeur Vaiss 1974;68: I. Menotti A, Capocaccia R, Conti S, et al. Identifying subsets of major risk factors in multivariate estimation of coronary risk. J Chron Dis 1977;30: Farchi G, Capocaccia R, Verdecchia A, et al. Risk factor changes and coronary heart disease in an observational study. Int J Epidemiol 1981;10: Mariotti S, Capocaccia R, Farchi G, et al. Differences in the incidence of coronary heart disease between north and south European cohorts of the Seven Countries Study. Eur Heart J 1982;3: Keys A, Aravanis C, Blackburn H, et al. Serum cholesterol and cancer mortality in the Seven Countries Study. Am J EpidemioI1985;121: Mariotti S, Capocaccia R, Farchi G, et al. Age, period, cohort and geographical area effects on the relationship between risk factors and coronary heart disease mortality. 15 year followup of the European cohorts of the Seven Countries Study. J Chron Dis 1986;39: Menotti A, Keys A, Aravanis C, et al. Hypertension and atherosclerosis: epidemiological aspects. The experience of southern Europe. In "Hypertension and Atherosclerosis" Satellite Meeting, 8th International Symposium on Atherosclerosis; 1988, Florence, Italy. Rome: CIC International Publ; p Menotti A, Keys A, Nissinen A, Kromhout 0, Seccareccia F. The Seven Countries Study: 25-year experience in three countries. In "Epidemiology of Atherosclerosis" Satellite Meeting, 8th International Symposium on Atherosclerosis; 1988, Porto Cervo, Italy. Rome: CIC International Publ; p Menotti A, Keys A, Blackburn H, et al. Twenty-year mortality and prediction of stroke in twelve cohorts of the Seven Countries Study. Int J Epidemiol 1990;19: Menotti A, Keys A, Kromhout 0, et al. Twenty-five year mortality from coronary heart disease and its prediction in five cohorts of middle-aged men in Finland, The Netherlands and Italy. Prev Med 1990; I 9: Kromhout 0, Nissinen A, Menotti A, et al. Total and HDL cholesterol and their correlates in elderly men in Finland, Italy and The Netherlands. Am J Epidemiol 1990; I 3 I : Menotti A, Keys A, Kromhout 0, et al. All cause mortality and its determinants in middle-aged men in Finland, The Netherlands, and Italy in a 25-year follow-up. J Epidemiol Community Health 1991;45: Kromhout 0, Katan MB, Menotti A, et al. Serum cholesterol and longterm death rates from suicide, accidents or violence (letter). Lancet 1992;340: Menotti A. Impact of international cardiovascular epidemiological studies on prevention: the Seven Countries Study. Can J Cardiol 1993;9 Suppl 0: Kromhout 0, Menotti A, Blackburn H, editors. The Seven Countries Study. A scientific adventure in cardiovascular disease epidemiology. Bilthoven, The Netherlands: Marjan Nijsen-Kramer Studio and RIVM; Hertog MGL, Kromhout 0, Aravanis C, et ai. Flavonoid intake and long-term risk of coronary heart disease and cancer in the

9 202 MENOTII Seven Countries Study. Arch Intern Med 1995;155: Ocke MC, Kromhout 0, Menotti A, et al. Average intake on anti-oxidant (pro) vitamins and subsequent cancer mortality in the 16 cohorts of the Seven Countries Study. IntJ Cancer 1995;61: Menotti A, Seccareccia F, Blackburn H, Keys A. Coronary mortality and its prediction in samples of US and Italian railroad employees in 25 years within the Seven Countries Study of Cardiovascular Diseases. Int J Epidemiol 1995;24: Verschuren WMM, Jacobs DR, Bloemberg BPM, et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the Seven Countries Study. JAMA 1995;274: Menotti A, Jacobs DR, Blackburn H, et al. Twenty-five-year prediction of stroke deaths in the Seven Countries Study. The role of blood pressure and its changes. Stroke 1996;27:381-7.

Saturated fat, vitamin C and smoking predict long-term population all-cause mortality rates in the Seven Countries Study

Saturated fat, vitamin C and smoking predict long-term population all-cause mortality rates in the Seven Countries Study International Epidemiological Association 2000 Printed in Great Britain International Journal of Epidemiology 2000;29:260 265 Saturated fat, vitamin C and smoking predict long-term population all-cause

More information

Predicting cardiovascular risk in the elderly in different European countries

Predicting cardiovascular risk in the elderly in different European countries European Heart Journal (2002) 23, 294 300 doi:10.1053/euhj.2001.2898, available online at http://www.idealibrary.com on Predicting cardiovascular risk in the elderly in different European countries S.

More information

I n a previous article dealing with the Italian rural cohorts of

I n a previous article dealing with the Italian rural cohorts of 19 CARDIOVASCULAR MEDICINE Coronary risk factors predicting early and late coronary deaths A Menotti, M Lanti... See end of article for authors affiliations... Correspondence to: Dr M Lanti, Associazione

More information

Preface: A Career in Nutrition and Cardiovascular Disease: From Research to Results to Public Health Policy

Preface: A Career in Nutrition and Cardiovascular Disease: From Research to Results to Public Health Policy 351 Public Health Reviews, Vol. 33, No 2, 351-362 Preface: A Career in Nutrition and Cardiovascular Disease: From Research to Results to Public Health Policy Key Words: Cardiovascular disease, coronary

More information

Nutrition & Diet for Healthy Lifestyles in Europe

Nutrition & Diet for Healthy Lifestyles in Europe Nutrition & Diet for Healthy Lifestyles in Europe Supported by the European Commission, Directorate General for Health & Consumer Protection & The Ministry of Health, Greece. Organized by University of

More information

Page down (pdf converstion error)

Page down (pdf converstion error) 1 of 6 2/10/2005 7:57 PM Weekly August6, 1999 / 48(30);649-656 2 of 6 2/10/2005 7:57 PM Achievements in Public Health, 1900-1999: Decline in Deaths from Heart Disease and Stroke -- United States, 1900-1999

More information

DESPITE WIDESPREAD agreement

DESPITE WIDESPREAD agreement ORIGINAL INVESTIGATION Cigarette Smoking and Mortality Risk Twenty-five Year Follow-up of the Seven Countries Study David R. Jacobs, Jr, PhD; Hisashi Adachi, MD; Ina Mulder, MSc; Daan Kromhout, PhD; Alessandro

More information

Modifying effects of dietary polyunsaturated fatty acid (PUFA) on levels of cholesterol and their implications for heart health

Modifying effects of dietary polyunsaturated fatty acid (PUFA) on levels of cholesterol and their implications for heart health Modifying effects of dietary polyunsaturated fatty acid (PUFA) on levels of cholesterol and their implications for heart health Robert Clarke Clinical Trial Service Unit University of Oxford 28 th May

More information

Pattern of lipid biomarkers and risk of cardiovascular disease

Pattern of lipid biomarkers and risk of cardiovascular disease Pattern of lipid biomarkers and risk of cardiovascular disease Robert Clarke Clinical Trial Service Unit University of Oxford 9 January 2017 Biomarkers for dietary fats Blood lipids (LDL, HDL, triglycerides,

More information

Cardiovascular Disease Prevention: Current Knowledge, Future Directions

Cardiovascular Disease Prevention: Current Knowledge, Future Directions Cardiovascular Disease Prevention: Current Knowledge, Future Directions Daniel Levy, MD Director, Framingham Heart Study Professor of Medicine, Boston University School of Medicine Editor-in-Chief, Journal

More information

EuroPrevent 2010 Fatal versus total events in risk assessment models

EuroPrevent 2010 Fatal versus total events in risk assessment models EuroPrevent 2010 Fatal versus total events in risk assessment models Pekka Jousilahti, MD, PhD,Research Professor National Institute for Health and Welfare, Finland Risk assessment models Estimates the

More information

Guidelines on cardiovascular risk assessment and management

Guidelines on cardiovascular risk assessment and management European Heart Journal Supplements (2005) 7 (Supplement L), L5 L10 doi:10.1093/eurheartj/sui079 Guidelines on cardiovascular risk assessment and management David A. Wood 1,2 * 1 Cardiovascular Medicine

More information

Going Coconut over Saturated Fat? Why So Much Confusion? Part 1 Interpreting Conflicting Research

Going Coconut over Saturated Fat? Why So Much Confusion? Part 1 Interpreting Conflicting Research Going Coconut over Saturated Fat? Why So Much Confusion? Part 1 Interpreting Conflicting Research Disclosures Alice H Lichtenstein Board Member/Advisory Panel Food and Nutrition Board, National Academies

More information

DECLARATION OF CONFLICT OF INTEREST. None

DECLARATION OF CONFLICT OF INTEREST. None DECLARATION OF CONFLICT OF INTEREST None Dietary changes and its influence on cardiovascular diseases in Asian and European countries Problems of Eastern European countries for cardiovascular disease prevention

More information

Diabetes Mellitus: A Cardiovascular Disease

Diabetes Mellitus: A Cardiovascular Disease Diabetes Mellitus: A Cardiovascular Disease Nestoras Mathioudakis, M.D. Assistant Professor of Medicine Division of Endocrinology, Diabetes, & Metabolism September 30, 2013 1 The ABCs of cardiovascular

More information

Alcohol, Fish, Fibre and Antioxidant Vitamins Intake do not Explain Population Differences in Coronary Heart Disease Mortality

Alcohol, Fish, Fibre and Antioxidant Vitamins Intake do not Explain Population Differences in Coronary Heart Disease Mortality International Journal of Epidemiology O International Epkdemlotogtcal Association 1996 Vol. 25, No. 4 Printed in Great Britain Alcohol, Fish, Fibre and Antioxidant Vitamins Intake do not Explain Population

More information

High density lipoprotein cholesterol and longevity.

High density lipoprotein cholesterol and longevity. Journal of Epidemiology and Community Health, 1987, 42, 60-65 High density lipoprotein cholesterol and longevity. ANCEL KEYS From the Division of Epidemiology, School of Public Health, University of Minnesota,

More information

Twenty-five-year Experience in Cardiovascular and All-causes Deaths

Twenty-five-year Experience in Cardiovascular and All-causes Deaths Clinical Studies The Seven Countries Study in Japan Twenty-five-year Experience in Cardiovascular and All-causes Deaths Hironori TOSHIMA, M.D., Yoshinori KOGA, M.D.,* Allessandro MENOTTI, M.D.,** Ancel

More information

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD

More information

Risk Factors for Heart Disease

Risk Factors for Heart Disease Developmental Perspectives on Health Disparities from Conception Through Adulthood Risk Factors for Heart Disease Philip Greenland, MD Harry W. Dingman Professor Chair, Department of Preventive Medicine

More information

The Oslo Diet-Heart Study

The Oslo Diet-Heart Study The Oslo -Heart Study Eleven-Year Report By PAUiL LEREN, M.D. SUMMARY The study deals with 412 men, aged 30 to 64 years, randomized 1 to 2 years after a first myocardial infarction. For the experimental

More information

Saturated fat- how long can you go/how low should you go?

Saturated fat- how long can you go/how low should you go? Saturated fat- how long can you go/how low should you go? Peter Clifton Baker IDI Heart and Diabetes Institute Page 1: Baker IDI Page 2: Baker IDI Page 3: Baker IDI FIGURE 1. Predicted changes ({Delta})

More information

ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults

ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults ORIGINAL INVESTIGATION C-Reactive Protein Concentration and Incident Hypertension in Young Adults The CARDIA Study Susan G. Lakoski, MD, MS; David M. Herrington, MD, MHS; David M. Siscovick, MD, MPH; Stephen

More information

Methods to evaluate a community s cardiovascular health for 25 x 25

Methods to evaluate a community s cardiovascular health for 25 x 25 Department of Cardiology Westmead Methods to evaluate a community s cardiovascular health for 25 x 25 A/Prof. Clara Chow Head Cardiac Program, The George Institute Program Director Community Based Cardiac

More information

ORIGINAL ARTICLE. C Pitsavos 1,2, DB Panagiotakos 1,2, C Chrysohoou 1, P Kokkinos 2, A Menotti 3,4, S Singh 2 and A Dontas 3,4 1.

ORIGINAL ARTICLE. C Pitsavos 1,2, DB Panagiotakos 1,2, C Chrysohoou 1, P Kokkinos 2, A Menotti 3,4, S Singh 2 and A Dontas 3,4 1. (2004) 18, 495 501 & 2004 Nature Publishing Group All rights reserved 0950-9240/04 $30.00 www.nature.com/jhh ORIGINAL ARTICLE Physical activity decreases the risk of stroke in middle-age men with left

More information

The Mediterranean Diet: The Optimal Diet for Cardiovascular Health

The Mediterranean Diet: The Optimal Diet for Cardiovascular Health The Mediterranean Diet: The Optimal Diet for Cardiovascular Health Vasanti Malik, ScD Research Scientist Department of Nutrition Harvard School of Public Health Cardiovascular Disease Prevention International

More information

Overview. The Mediterranean Diet: The Optimal Diet for Cardiovascular Health. No conflicts of interest or disclosures

Overview. The Mediterranean Diet: The Optimal Diet for Cardiovascular Health. No conflicts of interest or disclosures The Mediterranean Diet: The Optimal Diet for Cardiovascular Health No conflicts of interest or disclosures Vasanti Malik, ScD Research Scientist Department of Nutrition Harvard School of Public Health

More information

Central pressures and prediction of cardiovascular events in erectile dysfunction patients

Central pressures and prediction of cardiovascular events in erectile dysfunction patients Central pressures and prediction of cardiovascular events in erectile dysfunction patients N. Ioakeimidis, K. Rokkas, A. Angelis, Z. Kratiras, M. Abdelrasoul, C. Georgakopoulos, D. Terentes-Printzios,

More information

YOUNG ADULT MEN AND MIDDLEaged

YOUNG ADULT MEN AND MIDDLEaged BRIEF REPORT Favorable Cardiovascular Profile in Young Women and Long-term of Cardiovascular and All-Cause Mortality Martha L. Daviglus, MD, PhD Jeremiah Stamler, MD Amber Pirzada, MD Lijing L. Yan, PhD,

More information

Traditional Asian Soyfoods. Proven and Proposed Cardiovascular Benefits of Soyfoods. Reduction (%) in CHD Mortality in Eastern Finland ( )

Traditional Asian Soyfoods. Proven and Proposed Cardiovascular Benefits of Soyfoods. Reduction (%) in CHD Mortality in Eastern Finland ( ) Proven and Proposed Cardiovascular Benefits of Soyfoods Mark Messina, PhD, MS Soy Nutrition Institute Loma Linda University Nutrition Matters, Inc. markjohnmessina@gmail.com 1000 80 20 60 40 40 60 20 80

More information

Proven and Proposed Cardiovascular Benefits of Soyfoods

Proven and Proposed Cardiovascular Benefits of Soyfoods Proven and Proposed Cardiovascular Benefits of Soyfoods Mark Messina, PhD, MS Soy Nutrition Institute Loma Linda University Nutrition Matters, Inc. markjohnmessina@gmail.com Alpro Foundation 20 years symposium

More information

Key causes of preventable deaths in New Zealand In a population of 10,000 New Zealanders, every year there will be about:

Key causes of preventable deaths in New Zealand In a population of 10,000 New Zealanders, every year there will be about: Preventive care - Chronic Disease Management in primary care: a population perspective Rod Jackson University of Auckland New Zealand (22/11/8) Key causes of preventable deaths in New Zealand In a population

More information

Chronic Disease and Nutritional Underpinnings. Patrick Gélinas Dept. of Exercise and Sports Science USC Aiken

Chronic Disease and Nutritional Underpinnings. Patrick Gélinas Dept. of Exercise and Sports Science USC Aiken Chronic Disease and Nutritional Underpinnings Patrick Gélinas Dept. of Exercise and Sports Science USC Aiken Modern Diseases Difficult (impossible?) to gain information regarding diseases among prehistoric

More information

SUPPLEMENTAL MATERIAL

SUPPLEMENTAL MATERIAL SUPPLEMENTAL MATERIAL A Meta-analysis of LDL-C, non-hdl-c, and apob as markers of cardiovascular risk. Slide # Contents 2 Table A1. List of candidate reports 8 Table A2. List of covariates/model adjustments

More information

EUROPEAN SURVEY OF CARDIOVASCULAR DISEASE PREVENTION AND DIABETES EUROASPIRE IV. GUY DE BACKER Ghent University,Belgium

EUROPEAN SURVEY OF CARDIOVASCULAR DISEASE PREVENTION AND DIABETES EUROASPIRE IV. GUY DE BACKER Ghent University,Belgium EUROPEAN SURVEY OF CARDIOVASCULAR DISEASE PREVENTION AND DIABETES EUROASPIRE IV GUY DE BACKER Ghent University,Belgium ESC Congress 2012, aug.25-29th, Munich, Germany ESC Congress 2012, aug.25-29th, Munich,

More information

The relation between arterial blood pressure (BP) and

The relation between arterial blood pressure (BP) and Ten-Year Blood Pressure Trajectories, Cardiovascular Mortality, and Life Years Lost in 2 Extinction Cohorts: the Minnesota Business and Professional Men Study and the Zutphen Study Susanne M. A. J. Tielemans,

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Åsvold BO, Vatten LJ, Bjøro T, et al; Thyroid Studies Collaboration. Thyroid function within the normal range and risk of coronary heart disease: an individual participant

More information

Epidemiology of cardiovascular diseases in Europe

Epidemiology of cardiovascular diseases in Europe Public Health Nutrition: 4(2B), 441±457 DOI: 10.1079/PHN2001133 Epidemiology of cardiovascular diseases in Europe Daan Kromhout* Division of Public Health Research, National Institute of Public Health

More information

Heart Disease Genesis

Heart Disease Genesis Heart Disease Genesis The Ultimate Lecture on CAD origins Petr Polasek MD FRCPC FACC Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,

More information

Prevenzione cardiovascolare e cambiamento degli stili di vita. Gian Franco Gensini

Prevenzione cardiovascolare e cambiamento degli stili di vita. Gian Franco Gensini Prevenzione cardiovascolare e cambiamento degli stili di vita Gian Franco Gensini Main causes of death worldwide at all ages (year:: 2005) 17.5 milion Preventing Chronic Diseases A vital investiment. WHO

More information

Effects of whole grain intake on weight changes, diabetes, and cardiovascular Disease

Effects of whole grain intake on weight changes, diabetes, and cardiovascular Disease Effects of whole grain intake on weight changes, diabetes, and cardiovascular Disease Simin Liu, MD, ScD Professor of Epidemiology and Medicine Director, Center for Global Cardiometabolic Health Brown

More information

The health benefits of shellfish: What should we be promoting? Professor Bruce Griffin Nutrition Division Faculty of Health & Medical Sciences

The health benefits of shellfish: What should we be promoting? Professor Bruce Griffin Nutrition Division Faculty of Health & Medical Sciences The health benefits of shellfish: What should we be promoting? Professor Bruce Griffin Nutrition Division Faculty of Health & Medical Sciences What should we be promoting? Define health benefits in terms

More information

Understanding Cholesterol

Understanding Cholesterol Understanding Cholesterol Dr Mike Laker Published by Family Doctor Publications Limited in association with the British Medical Association IMPORTANT This book is intended not as a substitute for personal

More information

Implementing Type 2 Diabetes Prevention Programmes

Implementing Type 2 Diabetes Prevention Programmes Implementing Type 2 Diabetes Prevention Programmes Jaakko Tuomilehto Department of Public Health University of Helsinki Helsinki, Finland FIN-D2D Survey 2004 Prevalence of previously diagnosed and screen-detected

More information

incorporating the National Children s Hospital, Tallaght, Ireland

incorporating the National Children s Hospital, Tallaght, Ireland Hellenic J Cardiol 48: 55-63, 2007 Original Research Statistical Modelling of 10-Year Fatal Cardiovascular Disease Risk in Greece: The HellenicSCORE (a Calibration of the ESC SCORE Project) DEMOSTHENES

More information

Mediterranean Adequacy Index of Italian diets

Mediterranean Adequacy Index of Italian diets Public Health Nutrition: 7(7), 937 941 DOI: 10.1079/PHN2004557 Mediterranean Adequacy Index of Italian diets Adalberta Alberti-Fidanza* and Flaminio Fidanza Nutrition Section, Department of Internal Medicine,

More information

Dietary Reference Values: a Tool for Public Health

Dietary Reference Values: a Tool for Public Health HOGE GEZONDHEISRAAD Dietary Reference Values: a Tool for Public Health CONSEIL SUPERIEUR DE LA SANTE Belgian Dietary Reference Values for Energy and Macronutrients: FATS G. De Backer Brussels, February

More information

Cardiac patient quality of life. How to eat adequately?

Cardiac patient quality of life. How to eat adequately? Cardiac patient quality of life How to eat adequately? François Paillard CV Prevention Center CHU Rennes JESFC, Paris, 17/01/2013 Mrs. L. 55 yrs, Coronary artery disease, normal weight, mild hypertension

More information

Fruit & Vegetable Consumption and Mental Health

Fruit & Vegetable Consumption and Mental Health Fruit & Vegetable Consumption and Mental Health Saverio Stranges, MD, PhD, FAHA Department of Epidemiology & Biostatistics, Western University Department of Family Medicine, Western University Department

More information

Preventive Cardiology Scientific evidence

Preventive Cardiology Scientific evidence Preventive Cardiology Scientific evidence Professor David A Wood Garfield Weston Professor of Cardiovascular Medicine International Centre for Circulatory Health Imperial College London Primary prevention

More information

Fatty acids and cardiovascular health: current evidence and next steps

Fatty acids and cardiovascular health: current evidence and next steps Fatty acids and cardiovascular health: current evidence and next steps Emanuele Di Angelantonio, MD, PhD Department of Public Health and Primary Care NICE guidelines on fatty acids Eliminate the use of

More information

Baldness and Coronary Heart Disease Rates in Men from the Framingham Study

Baldness and Coronary Heart Disease Rates in Men from the Framingham Study A BRIEF ORIGINAL CONTRIBUTION Baldness and Coronary Heart Disease Rates in Men from the Framingham Study The authors assessed the relation between the extent and progression of baldness and coronary heart

More information

Epidemiologic Measure of Association

Epidemiologic Measure of Association Measures of Disease Occurrence: Epidemiologic Measure of Association Basic Concepts Confidence Interval for population characteristic: Disease Exposure Present Absent Total Yes A B N 1 = A+B No C D N 2

More information

Advanced IPD meta-analysis methods for observational studies

Advanced IPD meta-analysis methods for observational studies Advanced IPD meta-analysis methods for observational studies Simon Thompson University of Cambridge, UK Part 4 IBC Victoria, July 2016 1 Outline of talk Usual measures of association (e.g. hazard ratios)

More information

Antihypertensive Trial Design ALLHAT

Antihypertensive Trial Design ALLHAT 1 U.S. Department of Health and Human Services Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic National Institutes

More information

Saturated Fats: What is the Link to Cardiovascular Disease?

Saturated Fats: What is the Link to Cardiovascular Disease? Saturated Fats: What is the Link to Cardiovascular Disease? Benoît Lamarche, PhD Chair of Nutrition School of Nutrition INAF, Université Laval Québec, Canada CNS 2015 Winnipeg Disclosures Funding (last

More information

Dyslipidemia in women: Who should be treated and how?

Dyslipidemia in women: Who should be treated and how? Dyslipidemia in women: Who should be treated and how? Lale Tokgozoglu, MD, FACC, FESC Professor of Cardiology Hacettepe University Faculty of Medicine Ankara, Turkey. Cause of Death in Women: European

More information

International model for prevention of chronic disease: Finland experience

International model for prevention of chronic disease: Finland experience International model for prevention of chronic disease: Finland experience Erkki Vartiainen, MD, Professor, Assistant Director General 06/12/2011 Erkki Vartiainen 1 2 Start of the North Karelia project

More information

The Metabolic Syndrome: Is It A Valid Concept? YES

The Metabolic Syndrome: Is It A Valid Concept? YES The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA

More information

Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia

Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia (2004) 18, 545 551 & 2004 Nature Publishing Group All rights reserved 0950-9240/04 $30.00 www.nature.com/jhh REVIEW ARTICLE Prevalence, awareness, treatment and control of hypertension in North America,

More information

Food and nutrient intakes of Greek (Cretan) adults. Recent data for food-based dietary guidelines in Greece

Food and nutrient intakes of Greek (Cretan) adults. Recent data for food-based dietary guidelines in Greece British Journal of Nutrition (1999), 81, Suppl. 2, S71 S76 S71 Food and nutrient intakes of Greek (Cretan) adults. Recent data for food-based dietary guidelines in Greece Joanna Moschandreas and Anthony

More information

Northwestern University Feinberg School of Medicine Calculating the CVD Risk Score: Which Tool for Which Patient?

Northwestern University Feinberg School of Medicine Calculating the CVD Risk Score: Which Tool for Which Patient? Northwestern University Feinberg School of Medicine Calculating the CVD Risk Score: Which Tool for Which Patient? Donald M. Lloyd-Jones, MD, ScM, FACC, FAHA Senior Associate Dean Chair, Department of Preventive

More information

Appendix: Definition of variables in the studies included in the meta-analysis

Appendix: Definition of variables in the studies included in the meta-analysis Appendix: Definition of variables in the studies included in the meta-analysis Belonging to the article: Bogers RP, BemelmansWJE, Hoogenveen RT, Boshuizen HC, Woodward M, Knekt P, van Dam RM, Hu FB, Visscher

More information

Glycemic index, glycemic load, and the risk of acute myocardial infarction in middle-aged Finnish men:

Glycemic index, glycemic load, and the risk of acute myocardial infarction in middle-aged Finnish men: Glycemic index, glycemic load, and the risk of acute myocardial infarction in middle-aged Finnish men: The Kuopio Ischaemic Heart Disease Risk Factor Study Jaakko Mursu, Jyrki K. Virtanen, Tiina H. Rissanen,

More information

Adherence to a healthy diet in relation to cardiovascular incidence and risk markers: evidence from the Caerphilly Prospective Study

Adherence to a healthy diet in relation to cardiovascular incidence and risk markers: evidence from the Caerphilly Prospective Study DOI 10.1007/s00394-017-1408-0 ORIGINAL CONTRIBUTION Adherence to a healthy diet in relation to cardiovascular incidence and risk markers: evidence from the Caerphilly Prospective Study Elly Mertens 1,2

More information

Can foods change your health? Good fats and bad fats: what is the evidence? Kay-Tee Khaw. Main categories of fats

Can foods change your health? Good fats and bad fats: what is the evidence? Kay-Tee Khaw. Main categories of fats Can foods change your health? Good fats and bad fats: what is the evidence? Kay-Tee Khaw UNIVERSITY OF CAMBRIDGE Hong Kong July 6 213 Yerushalmy J Hilleboe HE NY State J Med 1957 Coronary heart disease

More information

Ancel Keys and the Seven Countries Study:

Ancel Keys and the Seven Countries Study: Ancel Keys and the Seven Countries Study: An Evidence-based Response to Revisionist Histories WHITE PAPER Commissioned by The True Health Initiative http://www.truehealthinitiative.org/ With emphasis on

More information

Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University

Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Biases in clinical research Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Learning objectives Describe the threats to causal inferences in clinical studies Understand the role of

More information

Controversies in Preventative Cardiology

Controversies in Preventative Cardiology Controversies in Preventative Cardiology Francisco Lopez-Jimenez, M.D., M.Sc, FACC, FAHA Professor of Medicine, Mayo Medical School Chair, Division of Preventive Cardiology Co-Director, Artificial Intelligence

More information

Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes?

Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes? Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes? Boston, MA November 7, 213 Edward S. Horton, MD Professor of Medicine Harvard Medical School Senior Investigator

More information

Intermediate Methods in Epidemiology Exercise No. 4 - Passive smoking and atherosclerosis

Intermediate Methods in Epidemiology Exercise No. 4 - Passive smoking and atherosclerosis Intermediate Methods in Epidemiology 2008 Exercise No. 4 - Passive smoking and atherosclerosis The purpose of this exercise is to allow students to recapitulate issues discussed throughout the course which

More information

Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up

Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up... Study Population: 340... Total Population: 500... Time Window of Baseline: 09/01/13 to 12/20/13... Time Window of Follow-up:

More information

Considering depression as a risk marker for incident coronary disease

Considering depression as a risk marker for incident coronary disease Considering depression as a risk marker for incident coronary disease Dr Adrienne O'Neil Senior Research Fellow Melbourne School of Population & Global Health The University of Melbourne & Visiting Fellow

More information

NOT-FED Study New Obesity Treatment- Fasting, Exercise, Diet

NOT-FED Study New Obesity Treatment- Fasting, Exercise, Diet NOT-FED Study New Obesity Treatment- Fasting, Exercise, Diet FASTING 16 hours a day EXCERCISE 150 min a week DIET Low carb NOSM Northern Research Conference, Kenora, 2018 R Minty, T O Driscoll, L Kelly,

More information

Comparison of diets of diabetic and non-diabetic elderly men in Finland, The Netherlands and Italy

Comparison of diets of diabetic and non-diabetic elderly men in Finland, The Netherlands and Italy (2000) 54, 181±186 ß 2000 Macmillan Publishers Ltd All rights reserved 0954±3007/00 $15.00 www.nature.com/ejcn Comparison of diets of diabetic and non-diabetic elderly men in Finland, The Netherlands and

More information

Folate, vitamin B 6, and vitamin B 12 are cofactors in

Folate, vitamin B 6, and vitamin B 12 are cofactors in Research Letters Dietary Folate and Vitamin B 6 and B 12 Intake in Relation to Mortality From Cardiovascular Diseases Japan Collaborative Cohort Study Renzhe Cui, MD; Hiroyasu Iso, MD; Chigusa Date, MD;

More information

Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes

Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes Katherine Baldock Catherine Chittleborough Patrick Phillips Anne Taylor August 2007 Acknowledgements This project was made

More information

Karri Silventoinen University of Helsinki and Osaka University

Karri Silventoinen University of Helsinki and Osaka University Karri Silventoinen University of Helsinki and Osaka University Childhood is an important phase of life and creates the base for all further life Childhood is the time of rapid physiological development

More information

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Latest Insights from the JUPITER Study John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Inflammation, hscrp, and Vascular Prevention

More information

Risk Stratification of ACS Patients. Frans Van de Werf, MD, PhD University of Leuven, Belgium

Risk Stratification of ACS Patients. Frans Van de Werf, MD, PhD University of Leuven, Belgium Risk Stratification of ACS Patients Frans Van de Werf, MD, PhD University of Leuven, Belgium Which type of ACS patients are we talking about to day? 4/14/2011 STEMI and NSTEMI in the NRMI registry from

More information

Supplemental table 1. Dietary sources of protein among 2441 men from the Kuopio Ischaemic Heart Disease Risk Factor Study MEAT DAIRY OTHER ANIMAL

Supplemental table 1. Dietary sources of protein among 2441 men from the Kuopio Ischaemic Heart Disease Risk Factor Study MEAT DAIRY OTHER ANIMAL ONLINE DATA SUPPLEMENT 1 SUPPLEMENTAL MATERIAL Pork Bacon Turkey Kidney Cream Cottage cheese Mutton and lamb Game (elk, reindeer) Supplemental table 1. Dietary sources of protein among 2441 men from the

More information

BY FLAMINIO FIDANZA Istituto di Scienta dell Alimentazione, Universita degli Studi, Perugia. Italy

BY FLAMINIO FIDANZA Istituto di Scienta dell Alimentazione, Universita degli Studi, Perugia. Italy Proceeding.7 of the Nictritiori Sociery (1991) 50. 519-526 519 The Mediterranean Italian diet: keys to contemporary thinking BY FLAMINIO FIDANZA Istituto di Scienta dell Alimentazione, Universita degli

More information

Key Nutritional Considerations & Lab Markers as Adjuncts in Effective Lipid Management. Carmen Ritz, MS Clinical Physiologist

Key Nutritional Considerations & Lab Markers as Adjuncts in Effective Lipid Management. Carmen Ritz, MS Clinical Physiologist Key Nutritional Considerations & Lab Markers as Adjuncts in Effective Lipid Management Carmen Ritz, MS Clinical Physiologist The Ideal Biomarker to identify risk for CVD Specific accurately identifies

More information

Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice

Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice (2005) 19, 801 807 & 2005 Nature Publishing Group All rights reserved 0950-9240/05 $30.00 www.nature.com/jhh ORIGINAL ARTICLE Prognostic significance of blood pressure measured in the office, at home and

More information

Prevention of Heart Disease. Giridhar Vedala, MD Cardiovascular Medicine

Prevention of Heart Disease. Giridhar Vedala, MD Cardiovascular Medicine Prevention of Heart Disease Giridhar Vedala, MD Cardiovascular Medicine What is Heart Disease? Heart : The most hard-working muscle of our body pumps 4-5 liters of blood every minute during rest Supplies

More information

Heart Failure and COPD: Common Partners, Common Problems. Nat Hawkins Liverpool Heart and Chest Hospital

Heart Failure and COPD: Common Partners, Common Problems. Nat Hawkins Liverpool Heart and Chest Hospital Heart Failure and COPD: Common Partners, Common Problems Nat Hawkins Liverpool Heart and Chest Hospital Disclosures: No conflicts of interest Common partners, common problems COPD in HF common partners

More information

Andrejs Kalvelis 1, MD, PhD, Inga Stukena 2, MD, Guntis Bahs 3 MD, PhD & Aivars Lejnieks 4, MD, PhD ABSTRACT INTRODUCTION. Riga Stradins University

Andrejs Kalvelis 1, MD, PhD, Inga Stukena 2, MD, Guntis Bahs 3 MD, PhD & Aivars Lejnieks 4, MD, PhD ABSTRACT INTRODUCTION. Riga Stradins University CARDIOVASCULAR RISK FACTORS ORIGINAL ARTICLE Do We Correctly Assess the Risk of Cardiovascular Disease? Characteristics of Risk Factors for Cardiovascular Disease Depending on the Sex and Age of Patients

More information

Statistical Fact Sheet Populations

Statistical Fact Sheet Populations Statistical Fact Sheet Populations At-a-Glance Summary Tables Men and Cardiovascular Diseases Mexican- American Males Diseases and Risk Factors Total Population Total Males White Males Black Males Total

More information

Blood Pressure Targets in Diabetes

Blood Pressure Targets in Diabetes Stockholm, 29 th August 2010 ESC Meeting Blood Pressure Targets in Diabetes Peter M Nilsson, MD, PhD Department of Clinical Sciences University Hospital, Malmö Sweden Studies on BP in DM2 ADVANCE RCT (Lancet

More information

Mediterranean Diet, Lifestyle Factors, and 10-Year Mortality -The HALE project-

Mediterranean Diet, Lifestyle Factors, and 10-Year Mortality -The HALE project- Mediterranean Diet, Lifestyle Factors, and 10-Year Mortality -The HALE project- Kim Knoops PhD-Student Wageningen University Supervisors: W.A. van Staveren C.P.G.M. de Groot D. Kromhout Outline of the

More information

Barnyard Brouhaha: What About Dairy and Eggs in the Diet? Edwin Cox, M.D. OLLI

Barnyard Brouhaha: What About Dairy and Eggs in the Diet? Edwin Cox, M.D. OLLI Barnyard Brouhaha: What About Dairy and Eggs in the Diet? Edwin Cox, M.D. OLLI Dairy and Eggs Good sources of protein Good sources of vitamin B12 Associated with controversy: risk regarding ASCVD risk

More information

Nutritional Risk Factors for Peripheral Vascular Disease: Does Diet Play a Role?

Nutritional Risk Factors for Peripheral Vascular Disease: Does Diet Play a Role? Nutritional Risk Factors for Peripheral Vascular Disease: Does Diet Play a Role? John S. Lane MD, Cheryl P. Magno MPH, Karen T. Lane MD, Tyler Chan BS, Sheldon Greenfield MD University of California, Irvine

More information

290 Biomed Environ Sci, 2016; 29(4):

290 Biomed Environ Sci, 2016; 29(4): 290 Biomed Environ Sci, 2016; 29(4): 290-294 Letter to the Editor Prevalence and Predictors of Hypertension in the Labor Force Population in China: Results from a Cross-sectional Survey in Xinjiang Uygur

More information

Red Alert for Women s Hearts Women and Cardiovascular Research in Europe

Red Alert for Women s Hearts Women and Cardiovascular Research in Europe Red Alert for Women s Hearts Women and Cardiovascular Research in Europe Marco Stramba-Badiale Director, Department of Rehabilitation Medicine, IRCCS Istituto Auxologico Italiano, Milan, Italy European

More information

Using the New Hypertension Guidelines

Using the New Hypertension Guidelines Using the New Hypertension Guidelines Kamal Henderson, MD Department of Cardiology, Preventive Medicine, University of North Carolina School of Medicine Kotchen TA. Historical trends and milestones in

More information

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: ARIC Manuscript Proposal # 1475 PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: Hypertension, left ventricular hypertrophy, and risk of incident hospitalized

More information

STABILITY Stabilization of Atherosclerotic plaque By Initiation of darapladib TherapY. Harvey D White on behalf of The STABILITY Investigators

STABILITY Stabilization of Atherosclerotic plaque By Initiation of darapladib TherapY. Harvey D White on behalf of The STABILITY Investigators STABILITY Stabilization of Atherosclerotic plaque By Initiation of darapladib TherapY Harvey D White on behalf of The STABILITY Investigators Lipoprotein- associated Phospholipase A 2 (Lp-PLA 2 ) activity:

More information

Prof. Renata Cífková, MD, CSc.

Prof. Renata Cífková, MD, CSc. Prof. Renata Cífková, MD, CSc. Head of the Department of Preventive Cardiology, Thomayer Teaching Hospital, Prague Focuses on arterial hypertension epidemiology, clinical trials, target organ damage prevention

More information

J-curve Revisited. An Analysis of Blood Pressure and Cardiovascular Events in the Treating to New Targets (TNT) Trial

J-curve Revisited. An Analysis of Blood Pressure and Cardiovascular Events in the Treating to New Targets (TNT) Trial J-curve Revisited An Analysis of Blood Pressure and Cardiovascular Events in the Treating to New Targets (TNT) Trial Sripal Bangalore, MD, MHA, Franz H Messerli, MD, Chuan-Chuan Wun, PhD, Andrea L. Zuckerman,

More information

Since 1980, obesity has more than doubled worldwide, and in 2008 over 1.5 billion adults aged 20 years were overweight.

Since 1980, obesity has more than doubled worldwide, and in 2008 over 1.5 billion adults aged 20 years were overweight. Impact of metabolic comorbidity on the association between body mass index and health-related quality of life: a Scotland-wide cross-sectional study of 5,608 participants Dr. Zia Ul Haq Doctoral Research

More information